Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Differentiating Electrolyte and Fluid Disorders

Differentiating Electrolyte and Fluid Disorders AbstractVasopressin or anti-diuretic hormone (ADH) is a nonapeptide that is synthesized in the hypothalamus and plays an important role in the control of the body’s osmotic balance, blood pressure regulation and kidney function. ADH induces expression of water transport proteins in the late distal tubule and collecting duct to increase water re-absorption. ADH is produced by neurons within the supraoptic nuclei of the hypothalamus, stored in secretary vesicles and transported through the hypothalamic-hypophyseal tract and released in the posterior pituitary. The secreted hormones then enter nearby fenestrated capillaries where they enter the body’s systemic circulation. These neurons express osmo receptors that are responsive to blood osmolarity and respond to changes as little as 2 mOsm/L.Therefore slight elevations in osmolarity result in secretion of ADH. ADH acts in the kidneys to increase water re-absorption, thus returning the osmolarity to baseline. ADH is also secreted in times of hypovolaemia. Decreased arterial blood volume is sensed by bar receptors in the left atrium, carotid artery and aortic arch and the signal transported to the vagus nerve which directly stimulates the release of ADH. ADH then promotes water re-absorption in the kidneys to increase effective arterial blood volume and increase blood pressure to maintain tissue perfusion. Osmolarity and volume status are the two greatest factors that affect ADH secretion. There are three pathologic states related to ADH. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Australasian Journal of Neuroscience de Gruyter

Differentiating Electrolyte and Fluid Disorders

Lear, Diane; Bruce, Leigh
Australasian Journal of Neuroscience , Volume 31 (2): 3 – Oct 1, 2021
Download PDF
3 pages

Loading next page...
 
/lp/de-gruyter/differentiating-electrolyte-and-fluid-disorders-2DrbkDEnva

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
© 2021 Diane Lear., published by Sciendo
eISSN
2208-6781
DOI
10.21307/ajon-2021-006
Publisher site
See Article on Publisher Site

Abstract

AbstractVasopressin or anti-diuretic hormone (ADH) is a nonapeptide that is synthesized in the hypothalamus and plays an important role in the control of the body’s osmotic balance, blood pressure regulation and kidney function. ADH induces expression of water transport proteins in the late distal tubule and collecting duct to increase water re-absorption. ADH is produced by neurons within the supraoptic nuclei of the hypothalamus, stored in secretary vesicles and transported through the hypothalamic-hypophyseal tract and released in the posterior pituitary. The secreted hormones then enter nearby fenestrated capillaries where they enter the body’s systemic circulation. These neurons express osmo receptors that are responsive to blood osmolarity and respond to changes as little as 2 mOsm/L.Therefore slight elevations in osmolarity result in secretion of ADH. ADH acts in the kidneys to increase water re-absorption, thus returning the osmolarity to baseline. ADH is also secreted in times of hypovolaemia. Decreased arterial blood volume is sensed by bar receptors in the left atrium, carotid artery and aortic arch and the signal transported to the vagus nerve which directly stimulates the release of ADH. ADH then promotes water re-absorption in the kidneys to increase effective arterial blood volume and increase blood pressure to maintain tissue perfusion. Osmolarity and volume status are the two greatest factors that affect ADH secretion. There are three pathologic states related to ADH.

Journal

Australasian Journal of Neuroscience – de Gruyter

Published: Oct 1, 2021

There are no references for this article.